Drawing strength from its presence in varied sectors, the leading corporate player is looking to ensure that all its subsidiaries pull out all stops to support the government in its efforts to contain the deadly coronavirus outbreak
With the latest announcement of a contribution of Rs 500 crore towards the PM-CARES fund, Reliance Industries has further bolstered its multi-pronged strategy to fight the novel coronavirus, or COVID-19, pandemic.
Drawing strength from its presence in varied sectors, the leading corporate player is looking to ensure that all its subsidiaries pull out all stops to support the government in its efforts to contain the deadly coronavirus outbreak.
Here are some of the key initiatives launched by the group and its philanthropic arm, the Reliance Foundation, to support and strengthen the country's fight against the coronavirus outbreak:
- Contribution of Rs 5 crore to the Chief Minister’s Relief Fund of Maharashtra
- Contribution of Rs 5 crore to the Chief Minister’s Relief Fund of Gujarat
- India’s first 100-bed exclusive COVID-19 hospital geared up in just two weeks to handle coronavirus patients
- To provide 50 lakh free meals in the next 10 days across India, with plans to provide more such meals in newer areas
- One lakh masks daily for health-workers and caregivers
- Thousands of personal protective equipment (PPEs) daily for health-workers and caregivers
- Free Fuel across the country to notified emergency response vehicles
- Jio seamlessly connecting nearly 40 crore individuals and thousands of organisations daily on its telecom backbone via ‘work from home’, ‘study from home’ and ‘health from home’ initiatives
- Reliance Retail providing Essential supplies daily for millions of Indians via stores and home deliveries
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
Earlier this month, the company, in collaboration with the Brihanmumbai Municipal Corporation (BMC), set up the country's first dedicated COVID-19 hospital. RIL has also built a fully-equipped isolation facility in Lodhivali, Maharashtra, and handed it over to the district authorities while Reliance Life Sciences is importing additional test kits and consumables for effective testing.(Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd)